Roche drug is given go-ahead
Roche received a welcome boost when European regulators approved Pegasys, the Swiss healthcare group's new treatment for hepatitis C. Pegasys is the group's only important new drug launch this year
Roche received a welcome boost when European regulators approved Pegasys, the Swiss healthcare group's new treatment for hepatitis C. Pegasys is the group's only important new drug launch this year